ICN expands Senetek's Kinerase license

- Last updated on GMT

Related tags: Medicine

ICN Pharmaceuticals has announced the signing of a license
agreement which amends its current manufacturing license with
Senetek to expand ICN's moisturising Kinerase product line.

ICN Pharmaceuticals has announced the signing of a license agreement which amends its current manufacturing license with Senetek to expand ICN's moisturising Kinerase product line. The new license covers kinetin (N6-furfuryladenine)-containing products in North America, Europe and Australia.

The expanded contract adds five new products to the Kinerase line, including new serum and cream formulations with highly stabilised Vitamin C, a Kinerase sunscreen formulation and new cream and lotion formulations. ICN has licensed the rights to both manufacture and advertise the products, said the company in a statement.

"This expanded license underscores ICN's commitment to dermatology as a worldwide therapeutic area of focus, and demonstrates our willingness to commit worldwide resources to the product line,"​ said Tim Tyson, ICN's chief operating officer and president.

Available in both a cream and lotion formulation, Kinerase is sold by approximately 2,500 dermatologists and plastic surgeons throughout the United States and Canada for improving the appearance and texture of sun-damaged facial skin and providing gentle moisturisation for a variety of skin types.

ICN​ is a research-based global pharmaceutical company making a broad range of prescription and non-prescription pharmaceuticals as well as cosmetics under the ICN brand name. Its research and new product development focuses on treatments for dermatology, infectious diseases and cancer.

Related products

show more

Sustainably-Sourced Guar for a happier planet

Sustainably-Sourced Guar for a happier planet

Solvay | 05-Jul-2021 | Case Study

Solvay is the world leader in guar derivatives with a broad sustainable portfolio. Since 2015, Solvay has decided to go one step further with its Sustainable...

Seeing is believing

Seeing is believing

Lycored SARL | 27-May-2021 | Technical / White Paper

Based on a recent clinical study, subjects supplementing with Lycoderm™ showed evidence of a statistically significant increase in skin carotenoid levels;...

Related suppliers

Follow us

Products

View more

Webinars

Indie Pioneers Podcast

Indie Pioneers Podcast